|
HY-12887-25mg
|
MedChemexpress LLC
|
Piclamilast [CAS 144035-83-6]
|
|
COVID-19-immunoregulation
|
|
|
HY-12887-5mg
|
MedChemexpress LLC
|
Piclamilast [CAS 144035-83-6]
|
|
COVID-19-immunoregulation
|
|
|
HY-12887-50mg
|
MedChemexpress LLC
|
Piclamilast [CAS 144035-83-6]
|
|
COVID-19-immunoregulation
|
|
|
HY-12887-1mL
|
MedChemexpress LLC
|
Piclamilast [CAS 144035-83-6] (10mM in DMSO)
|
|
COVID-19-immunoregulation
|
|
|
HY-101676-10mg
|
MedChemexpress LLC
|
RG-12525 [CAS 120128-20-3]
|
|
Metabolism-sugar/lipid metabolism
|
|
|
HY-101676-100mg
|
MedChemexpress LLC
|
RG-12525 [CAS 120128-20-3]
|
|
Metabolism-sugar/lipid metabolism
|
|
|
HY-101676-25mg
|
MedChemexpress LLC
|
RG-12525 [CAS 120128-20-3]
|
|
Metabolism-sugar/lipid metabolism
|
|
|
HY-101676-5mg
|
MedChemexpress LLC
|
RG-12525 [CAS 120128-20-3]
|
|
Metabolism-sugar/lipid metabolism
|
|
|
HY-101676-50mg
|
MedChemexpress LLC
|
RG-12525 [CAS 120128-20-3]
|
|
Metabolism-sugar/lipid metabolism
|
|
|
HY-101676-1mL
|
MedChemexpress LLC
|
RG-12525 [CAS 120128-20-3] (10mM in DMSO)
|
|
Metabolism-sugar/lipid metabolism
|
|
|
HY-18099-10mg
|
MedChemexpress LLC
|
S1RA [CAS 878141-96-9]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-18099-5mg
|
MedChemexpress LLC
|
S1RA [CAS 878141-96-9]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-18099-1mL
|
MedChemexpress LLC
|
S1RA [CAS 878141-96-9] (10mM in DMSO)
|
|
Neuroscience-Neuromodulation
|
|
|
HY-15039-1mg
|
MedChemexpress LLC
|
SSR240612 [CAS 464930-42-5]
|
|
COVID-19-immunoregulation
|
|
|
HY-15039-10mg
|
MedChemexpress LLC
|
SSR240612 [CAS 464930-42-5]
|
|
COVID-19-immunoregulation
|
|
|
HY-15039-25mg
|
MedChemexpress LLC
|
SSR240612 [CAS 464930-42-5]
|
|
COVID-19-immunoregulation
|
|
|
HY-15039-5mg
|
MedChemexpress LLC
|
SSR240612 [CAS 464930-42-5]
|
|
COVID-19-immunoregulation
|
|
|
HY-13402A-10mg
|
MedChemexpress LLC
|
Varespladib (sodium) [CAS 172733-42-5]
|
|
COVID-19-immunoregulation
|
|
|
HY-13402A-100mg
|
MedChemexpress LLC
|
Varespladib (sodium) [CAS 172733-42-5]
|
|
COVID-19-immunoregulation
|
|
|
HY-13402A-25mg
|
MedChemexpress LLC
|
Varespladib (sodium) [CAS 172733-42-5]
|
|
COVID-19-immunoregulation
|
|
|
HY-13402A-5mg
|
MedChemexpress LLC
|
Varespladib (sodium) [CAS 172733-42-5]
|
|
COVID-19-immunoregulation
|
|
|
HY-13402A-50mg
|
MedChemexpress LLC
|
Varespladib (sodium) [CAS 172733-42-5]
|
|
COVID-19-immunoregulation
|
|
|
HY-13402-10mg
|
MedChemexpress LLC
|
Varespladib [CAS 172732-68-2]
|
|
COVID-19-immunoregulation
|
|
|
HY-13402-100mg
|
MedChemexpress LLC
|
Varespladib [CAS 172732-68-2]
|
|
COVID-19-immunoregulation
|
|
|
HY-13402-25mg
|
MedChemexpress LLC
|
Varespladib [CAS 172732-68-2]
|
|
COVID-19-immunoregulation
|
|
